Sennosides, Docusate Sodium is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Cardinal Health. The primary component is Docusate Sodium; Sennosides.
| Product ID | 70000-0403_7c4b0aef-6eff-4bde-e053-2991aa0a401f |
| NDC | 70000-0403 |
| Product Type | Human Otc Drug |
| Proprietary Name | Sennosides, Docusate Sodium |
| Generic Name | Sennosides, Docusate Sodium |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-01-10 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Labeler Name | Cardinal Health |
| Substance Name | DOCUSATE SODIUM; SENNOSIDES |
| Active Ingredient Strength | 50 mg/1; mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-01-10 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph not final |
| Application Number | part334 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2019-01-10 |
| Marketing End Date | 2019-01-10 |
| Ingredient | Strength |
|---|---|
| DOCUSATE SODIUM | 50 mg/1 |
| SPL SET ID: | 7c4b0aef-6efe-4bde-e053-2991aa0a401f |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0536-1167 | Sennosides, Docusate Sodium | Sennosides, Docusate Sodium |
| 0904-6723 | Sennosides, Docusate sodium | Sennosides, Docusate sodium |
| 55154-8076 | Sennosides, Docusate sodium | Sennosides, Docusate sodium |
| 69842-409 | SENNOSIDES, DOCUSATE SODIUM | SENNOSIDES, DOCUSATE SODIUM |
| 70000-0403 | Sennosides, Docusate Sodium | Sennosides, Docusate Sodium |
| 70000-0405 | Sennosides, Docusate Sodium | Sennosides, Docusate Sodium |
| 70518-2288 | Sennosides, Docusate Sodium | Sennosides, Docusate Sodium |
| 69618-049 | Sennosides and Docusate Sodium | Sennosides, Docusate Sodium |
| 69618-065 | Sennosides and Docusate Sodium | Sennosides, Docusate Sodium |